Stock Events

Stock Events

IQVIA 

$262.59
145
+$3.09+1.19%Wednesday 06:54

Statistics

Day High
262.59
Day Low
262.58
52W High
281.07
52W Low
156.06
Volume
4
Avg. Volume
-
Mkt Cap
43.27B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Feb 11Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
2.82
3.07
3.33
3.58
Expected EPS
3.583182
Actual EPS
N/A

Financials

8.34%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
16.31BRevenue
1.36BNet Income

Analyst Ratings

$310.25Average Price Target
The highest estimate is ⁦346.00⁩.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
92%
Hold
8%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IQV.BOATS. It's not an investment recommendation.
Microsoft
53
MSFT
Amazon
49
AMZN
NVIDIA
47
NVDA
Alphabet
47
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Charles River Laboratories International
CRL
Mkt Cap17.16B
Charles River Laboratories provides a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries, competing directly with IQVIA's research services.
Icon Energy
ICON
Mkt Cap3.73M
ICON plc offers clinical research services, directly competing with IQVIA in the contract research organization (CRO) space, providing full-service clinical development services.
Medpace
MEDP
Mkt Cap18.24B
Medpace Holdings is a scientifically-driven, global full-service clinical contract research organization (CRO) that competes with IQVIA in providing phase I-IV clinical development services to the pharmaceutical and biotech industry.
Mettler-Toledo International
MTD
Mkt Cap33.56B
Mettler-Toledo International Inc. provides precision instruments and services for professional use, including drug development and research, overlapping with some of IQVIA's analytical and laboratory services.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific Inc. offers analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with IQVIA in the life sciences and laboratory services market.
Quest Diagnostics
DGX
Mkt Cap27.79B
Quest Diagnostics Incorporated provides diagnostic testing, information, and services, including clinical trials testing which competes with IQVIA's services in the healthcare and diagnostics market.

About

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Show More
CEO
ISIN
US46266C1053

Listings

MI
IT
1IQV.MI
LSE
GB
0JDM.LSE
MU
DE
QTS.MU
XETRA
DE
QTS.XETRA

0 Comments

Share your thoughts

FAQs

What is IQVIA stock price today?▼
The current price of IQV.BOATS is $262.59 USD — it has increased by +1.19% in the past 24 hours. Watch IQVIA stock price performance more closely on the chart.
What is IQVIA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange IQVIA stocks are traded under the ticker IQV.BOATS.
What is IQVIA market cap?▼
Today IQVIA has the market capitalization of 43.27B
When is the next IQVIA earnings date?▼
IQVIA is going to release the next earnings report on February 11, 2027.
What were IQVIA earnings last quarter?▼
IQV.BOATS earnings for the last quarter are 3.34 USD per share, whereas the estimation was 3.26 USD resulting in a +2.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IQVIA revenue for the last year?▼
IQVIA revenue for the last year amounts to 16.31B USD.
What is IQVIA net income for the last year?▼
IQV.BOATS net income for the last year is 1.36B USD.
In which sector is IQVIA located?▼
IQVIA operates in the Other sector.
When did IQVIA complete a stock split?▼
IQVIA has not had any recent stock splits.